Clinical Trials Directory

Trials / Completed

CompletedNCT05934695

Lymphedema Severity on Shoulder Joint Function and Muscle Activation Patterns in Breast Cancer Survivors

The Impact of Lymphedema Severity on Shoulder Joint Function and Muscle Activation Patterns in Breast Cancer Survivors: A Cross-Sectional Study

Status
Completed
Phase
Study type
Observational
Enrollment
75 (actual)
Sponsor
Ahram Canadian University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Breast cancer-related lymphedema (BCRL) is a common complication affecting the upper extremity following breast cancer treatment. This study aims to investigate the relationship between lymphedema severity and shoulder joint function and muscle activation patterns in breast cancer survivors.

Conditions

Interventions

TypeNameDescription
OTHERLymphedema severity stratificationParticipants will be stratified into one of three lymphedema severity groups based on the International Society of Lymphology lymphedema severity staging: Mild (stage 1): swelling with pitting; normal skin and tissue turgor Moderate (stage 2): swelling with pitting; dermal thickening; skin changes without distortional warty-overgrowth Severe (stage 3): swelling with non-pitting; warty overgrowth or elephantiasis folds

Timeline

Start date
2023-06-30
Primary completion
2024-01-03
Completion
2024-01-03
First posted
2023-07-07
Last updated
2024-01-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05934695. Inclusion in this directory is not an endorsement.